| __timestamp | Iovance Biotherapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 293000 |
| Thursday, January 1, 2015 | 15470000 | 1002000 |
| Friday, January 1, 2016 | 28037000 | 888000 |
| Sunday, January 1, 2017 | 71615000 | 19623000 |
| Monday, January 1, 2018 | 99828000 | 30421000 |
| Tuesday, January 1, 2019 | 166023000 | 34794000 |
| Wednesday, January 1, 2020 | 201727000 | 28304000 |
| Friday, January 1, 2021 | 259039000 | 56886000 |
| Saturday, January 1, 2022 | 294781000 | 100894000 |
| Sunday, January 1, 2023 | 344077000 | 159765000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Iovance Biotherapeutics, Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Iovance Biotherapeutics has consistently increased its R&D spending, culminating in a 2023 expenditure that is over 12 times its 2014 level. This reflects a robust growth trajectory and a strong focus on pioneering new therapies. In contrast, Viridian Therapeutics, while also increasing its R&D budget, has shown a more moderate growth, with its 2023 spending being approximately 5 times that of 2014. This comparison highlights Iovance's aggressive strategy in the biotech landscape, potentially positioning it as a leader in innovation. As the industry continues to advance, these spending patterns may offer insights into future breakthroughs and market leadership.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.